Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent

Journal of the National Cancer Institute

Volumn 96, Issue 9, 2004, Pages 703-708

  Kobayashi, Hisataka ^a   Kawamoto, Satomi ^d   Sakai, Yoshio ^a   Choyke, Peter L ^a   Star, Robert A ^c   Brechbiel, Martin W ^b   Sato, Noriko ^a   Tagaya, Yutaka ^a   Morris, John C ^a   Waldmann, Thomas A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DENDRIMER; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GENERATION 6 POLYAMIDOAMINE DENDRIMER; NANOPARTICLE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LYMPH FLOW; LYMPHATIC DRAINAGE; MAGNETIC RESONANCE ANGIOGRAPHY; MAMMOGRAPHY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENTINEL LYMPH NODE; XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; EXPERIMENTAL NEOPLASM; FEMALE; INSTRUMENTATION; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOGRAPHY; METHODOLOGY; NANOTECHNOLOGY; PATHOLOGY; RADIOGRAPHY; THREE DIMENSIONAL IMAGING;

ANIMALS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; IMAGING, THREE-DIMENSIONAL; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOGRAPHY; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NANOTECHNOLOGY; TRANSPLANTATION, HETEROLOGOUS;

EID: 2442487937     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh124     Document Type: Article

References (26)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
2. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80: 1188-97.
3. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 1983;52:1551-7.
4. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001;19:3817-27.
5. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50.
6. Bass SS, Cox CE, Ku NN, Berman C, Reintgen DS. The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 1999;189:183-94.
7. Veronesi U, Galimberti V, Zurrida S, Pigatto F, Veronesi P, Robertson C. et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001;37:454-8.
8. Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, et al. Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer 1998;83:1362-8.
9. Alazraki NP, Styblo T, Grant SF, Cohen C, Larsen T, Aarsvold JN. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe. Semin Nucl Med 2000;30:56-64.
10. Alazraki NP, Styblo T, Grant SF, Cohen C, Larsen T, Waldrop S, et al. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma detecting probe. Radiol Clin North Am 2001;39: 947-56.
11. Guller U, Nitzsche E, Moch H, Zuber M. Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients? J Natl Cancer Inst 2003;95:1040-43.
12. Suga K, Yuan Y, Ogasawara N, Okada M, Matsunaga N. Localization of breast sentinel lymph nodes by MR lymphography with a conventional gadolinium contrast agent. Preliminary observations in dogs and humans. Acta Radiol 2003;44:35-42.
13. Torchia MG, Nason R, Danzinger R, Lewis JM, Thliveris JA. Interstitial MR lymphangiography for the detection of sentinel lymph nodes. J Surg Oncol 2001;78:151-6.
14. Torchia MG, Misselwitz B. Combined MR lymphangiography and MR imaging-guided needle localization of sentinel lymph nodes using Gadomer-17. AJR Am J Roentgenol 2002;179:1561-5.
15. Kobayashi H, Sato N, Hiraga A, Saga T, Nakamoto Y, Ueda H, et al. 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with references to their pharmacokinetic properties. Magn Reson Med 2001;45:454-60.
16. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988;54:105-15.
17. Lucchini F, Sacco MG, Hu N, Villa A, Brown J, Cesano L, et al. Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice. Cancer Lett 1992;64:203-9.
18. Rovero S, Amici A, Carlo ED, Bei R, Nanni P, Quaglino E, et al. DAN vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice. J Immunol 2000;165:5133-42.
19. Tagaya Y, Burton JD, Miyamoto Y, Waldmann TA. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J 1996;15:4928-39.
20. Leong SP. Selective sentinel lymphadenectomy for malignant melanoma. Surg Clin North Am 2003;83:157-85.
21. Morita ET. Lymphoscintigraphy in the detection of sentinel lymph nodes. Cancer Treat Res 2002;111:9-37.
22. Kobayashi H, Sato N, Kawamoto S, Saga T, Hiraga A, Haque TL, et al. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer. Bioconjug Chem 2001;12:100-07.
23. Kobayashi H, Kawamoto S, Choyke PL, Sato N, Knopp MV, Star RA, et al. Comparison of the dendrimer-based macromolecular contrast agents for the dynamic micro-magnetic resonance lymphangiography. Magn Reson Med 2003;50:758-66.
24. Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW. Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res 2003;63:271-6.
25. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer [published erratum appears in N Engl J Med 2003;349:1010]. N Engl J Med 2003;348:2491-9.
26. Tardy B, Guy C, Barral G, Page Y, Ollagnier M, Bertrand JC. Anaphylactic shock induced by intravenous gadopentetate dimeglumine. Lancet 1992; 339:494.